期刊文献+

2型糖尿病合并冠心病患者血清内脂素和视黄醇结合蛋白4的临床意义 被引量:4

The Roles of Serum Visfatin and Retinol Binding Protein 4 in Patients with Type2 Diabetes Mellitus Complicated with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨血清内脂素(visfatin)和视黄醇结合蛋白4(RBP4)水平与2型糖尿病(T2DM)合并冠心病(CHD)的临床意义。方法选取单纯T2DM(T2DM组)患者61例、T2DM合并CHD(T2DM+CHD组)患者58例、单纯CHD(CHD组)患者60例、门诊健康体检者(对照组)60例,检测各组血清内脂素、RBP4水平、空腹血糖(FBG)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)水平,HbAlc和空腹血清胰岛素(FINS),计算胰岛素抵抗指数(HOMA—IR)、体重指数(BMI)及腰臀比(WHR),并作相关性分析。结果T2DM+CHD组血清内脂素和RBP4水平均明显高于T2DM组、CHD组和对照组,差异均有统计学意义(q=2.56—3.13,均P〈0.05)。T2DM+CHD组内脂素水平与WHR、RBP4、TG和HOMA.IR呈正相关(r=0.27—0.52,均P〈0.05);T2DM与RBP4和HbAlc密切相关(OR=2.09~3.67,P=0.05),T2DM合并CHD与内脂素、RBP4和TG密切相关(OR=2.13~3.81,P=0.05)。结论血清内脂素和RBP4与T2DM合并CHD的发病有一定联系。 Objective To evaluate the roles and clinical significance of visfatin, RBP4, T2DM with CHD in patients. Methods Serum sample were taken from 61 patients with T2DM, 58 patients with T2DM complicated with CHD, 60 patients with CHD and 60 normal controls, visfatin and RBP4 were measured with EHSA, and we also measured the fasting blood glucose(FBG), total choles- terol(TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) levels, HbAlc and fasting serum insulin(HNS), HOMA-IR, body mass index (BMI) and waist to hip ratio(WHR), Spearman analysis and Logistic analysis were used. Results The patients with T2DM complicated with CHD had significantly higher levels of visfatin and RBP4 than T2DM group, CHD group and control group(q = 2.56 - 3.13, all P 〈 0.05) ; Spearman analysis showed the visfatin level was positively correlated with WHR, RBP4, TG and HOMA-IR (r= 0.27~0.52,all P 〈 0.05), Logistic analysis showed RBP4 and HbA1 c were closely related to T2DM ( B = 0.69, P = 0.02; B = 0.16, P = 0.02) ; visfatin, RBP4 and TG were closely related to T2DM complicated with CHD ( B = 0.63, P = 0.04; B = 0.75, P = 0.03 ; B = 0.98, P =0.03). Conclusions Serum visfatin and RBP4 may play an important role in the development of T2DM complicated with CHD.
作者 张高健 邱蔚
出处 《心脑血管病防治》 2013年第3期186-189,共4页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 内脂素 视黄醇结合蛋白4 2型糖尿病 冠状动脉性心脏病 Visfatin RBP4 Type2 diabetes mellitus Coronary heart disease
  • 相关文献

参考文献11

  • 1Pories WJ, Mehaffey JH, Staton KM. The surgical treatment of type two diabetes mellitus[J]. Surg Clin North Am, 2011,91 (4) : 821 - 836.
  • 2Fuknbara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin [ J ]. Science, 2005, 307 (5708) :426 - 430.
  • 3Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ [J]. Mol Cell Endocrinol,2010,316(2) : 129 - 39.
  • 4陈灏珠,主编.实用内科学[M] 第12版.北京:人民卫生出版社,2005.1 579-1 582.
  • 5国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组报告.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-76.
  • 6Harmnarstedt A, Pihlajam:i J, Rotter Sopasakis V, et 01. Visfatin is an adipokine, but it is not regulated by thiazolidinediones [ J]. J Clin En- docrinol Metab,2006,91(3) : 1181 - 1184.
  • 7Kelly KR, Kashyap SR, O'Leary VB, et al. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients[J]. Obesity (Silver Spring) ,2010,18(4) :563 - 666.
  • 8Frey SK, Spranger J, Henze A, et ol. Factors that influence retinol-bind- ing protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus [ J ]. Metabolism, 2009,58(10) : 1386 - 1392.
  • 9Shaker O, E1-Shehaby A, Zakaria A, et 01. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver [ J ]. Clin Biechem, 2011,44 ( 17 - 18) : 1457 - 1463.
  • 10E1-Mesallamy HO, Kassem DH, El-Demerdash E, et al. Vaspin and vis- fatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus [ J ]. Metabolism, 2011,60 ( 1 ) : 63 -70.

共引文献361

同被引文献46

  • 1李福娥,方勇菊,杨宇红.老年急性冠脉综合征与脂蛋白(a)及血浆纤维蛋白原的关系[J].临床医药实践,2007,16(9):821-822. 被引量:1
  • 2刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1233
  • 3Becker DE.Fundamentals of Electrocardiography Interpretation[J].Anesth Prog,2006,53(2):53-64.
  • 4Olgin JE.Approach to the patient with suspected arrhythmia.In:Goldman L,Schafer AI,eds.Cecil Medicine[M].24th ed.Philadelphia,Pa:Saunders Elsevier,2011:62.
  • 5Smith SC,Amsterdam E,Balady GJ,et al.Prevention Conference V:beyond secondary prevention:identifying the high-risk patient for primary prevention:tests for silent and inducible ischemia:Writing GroupⅡ[J].Circulation,2000,101(1):e12-e16.
  • 6Kalashnikov Vlu,Mitriagina SN,Syrkin AL,et al.Cost-effect Clinical analysis in choice of methods of coronary heart disease diagnosis[J].Ter Arkh,2008,80(4):8-11.
  • 7Nair CK,Khan IA,Esterbrooks DJ,et al.Diagnostic and prognostic value of Holter-Detected ST-Segment deviation in unselected patients with chest pain referred for coronary angiography[J].Chest,2001,120(3):834-839.
  • 8Von Eynatten M,Breitling L P,Roos M,et al.Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease A 10-year Prospective Study[J].Arteriosclerosis,thrombosis,and vascular biology,2012,32(9):2327-2335.
  • 9DeBoerMD.Obesity,systemicinf lammation,andincreas edriskforcardiovasculardiseaseanddiabetesamongadole scents:aneedforscreeningtoolstotargetinterventions[J].Nutrition,2013,29(2):379-386.
  • 10VanderVeldeM,MatsushitaK,CoreshJ,etal.Lowerestim atedglomerularfiltrationrateandhigheralbuminuriaar eassociatedwithall-causeandcardiovascularmortality.Acollaborativemeta-analysisofhigh- riskpopulationcohorts[J].Kidneyinternation al,2011,79(12):1341-1352.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部